atomoxetine hydrochloride has been researched along with Aggression in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Anagnostou, E | 1 |
Benarous, X; Cohen, D; Consoli, A; Ferrafiat, V; Gérardin, P; Guilé, JM; Zammit, J | 1 |
Barzman, DH; Patel, BD | 1 |
Holzer, B; Lehman, R; Lopes, V | 1 |
Gardner, D; Gorman, DA; Hirsch, L; Pringsheim, T | 1 |
Ayyash, HF; Banerjee, S | 1 |
Ball, SG; Bangs, M; Donnelly, C; Jin, L; Spencer, TJ; Trzepacz, P; Witte, MM; Zhang, S | 1 |
Niederhofer, H | 1 |
Hartman, K; Henderson, TA | 1 |
Henderson, TA | 1 |
Acharya, N; Allen, AJ; Bangs, ME; Dellva, MA; Polzer, J; Tauscher-Wisniewski, S; Watson, SB; Wilens, TE; Zhang, S | 1 |
4 review(s) available for atomoxetine hydrochloride and Aggression
Article | Year |
---|---|
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders | 2018 |
Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Impulsive Behavior; Pharmacogenetics; Precision Medicine; Propylamines; Psychotropic Drugs; Treatment Outcome | 2013 |
The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysi
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Conduct Disorder; Humans | 2015 |
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases as Topic; Double-Blind Method; Female; Hostility; Humans; Male; Methylphenidate; Middle Aged; Odds Ratio; Proportional Hazards Models; Propylamines | 2007 |
3 trial(s) available for atomoxetine hydrochloride and Aggression
Article | Year |
---|---|
Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Propylamines; Time Factors; Treatment Outcome; Weight Gain | 2013 |
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Hostility; Humans; Male; Propylamines; Psychiatric Status Rating Scales; Treatment Outcome; Vital Signs | 2009 |
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases as Topic; Double-Blind Method; Female; Hostility; Humans; Male; Methylphenidate; Middle Aged; Odds Ratio; Proportional Hazards Models; Propylamines | 2007 |
5 other study(ies) available for atomoxetine hydrochloride and Aggression
Article | Year |
---|---|
Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention; Child; Conduct Disorder; Drug Tolerance; Female; Humans; Male | 2020 |
Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder?
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Hostility; Humans; Male; Propylamines | 2008 |
Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.
Topics: Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Cholinesterase Inhibitors; Drug Synergism; Humans; Male; Methylphenidate; Propylamines; Time Factors; Treatment Outcome | 2011 |
Aggression, mania, and hypomania induction associated with atomoxetine.
Topics: Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Humans; Neurotransmitter Uptake Inhibitors; Norepinephrine; Propylamines | 2004 |
Mania induction associated with atomoxetine.
Topics: Aggression; Anger; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Drug Therapy, Combination; Guanfacine; Humans; Irritable Mood; Male; Propylamines; Sympathomimetics; Violence | 2004 |